News
-
-
PRESS RELEASE
Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA)
Biotest AG reaches a significant milestone by submitting a Biologics License Application for Fibrinogen to the US FDA, aiming to address fibrinogen deficiency -
-
PRESS RELEASE
Minister of Economic Affairs Mansoori and Lord Mayor Benz visit Biotest's plasma center in Darmstadt and call for plasma donations
Minister of Economic Affairs Mansoori and Lord Mayor Benz visit Biotest's plasma center in Darmstadt to promote plasma donations and secure the long-term supply of plasma. Biotest AG emphasizes the importance of plasma donation in treating various illnesses -
-
PRESS RELEASE
Biotest increases revenues in the first 9 months by 4.5% to Euro 523 million
Biotest AG reports 4.5% revenue growth in first 9 months, reaching Euro 523 million. Product sales rise by 13.7%. Adjusted EBIT remains stable. Marketing authorization application submitted for Fibrinogen Concentrate (BT524). Outlook adjusted -
-
-
-
PRESS RELEASE
Biotest and SteinCares partner to improve access to plasma-derived products in Latin America
Biotest partners with SteinCares to enhance access to plasma-derived products in Latin America, starting with Haemoctin® for hemophilia patients. Financial and strategic collaboration aims to expand commercial footprint in LATAM region
